AI Article Synopsis

  • The case highlighted that recovering from renal damage caused by warfarin-related nephropathy can be a prolonged process.
  • Long-term follow-up is essential after starting dialysis for patients affected by this condition.
  • Monitoring and management are crucial in addressing the complications associated with warfarin use and kidney health.

Article Abstract

We experienced a case in which improving the renal damage caused by warfarin-related nephropathy took a long time. It is important to follow up for a long time after the initiation of dialysis due to warfarin-related nephropathy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133074PMC
http://dx.doi.org/10.1002/ccr3.4105DOI Listing

Publication Analysis

Top Keywords

warfarin-related nephropathy
12
long time
8
nephropathy case
4
case report
4
report delayed
4
delayed renal
4
renal function
4
function improvement
4
improvement experienced
4
experienced case
4

Similar Publications

Warfarin-related nephropathy: unveiling the hidden dangers of anticoagulation.

Clin Exp Med

July 2024

Department of Nephrology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Warfarin-related nephropathy (WRN) is defined as acute kidney injury subsequent to excessive anticoagulation with warfarin. Patients with mechanical prosthetic valves require long-term anticoagulant therapy. Nonetheless, warfarin remains the sole available option for anticoagulant therapy.

View Article and Find Full Text PDF

Acute Kidney Injury in Different Anticoagulation Strategies: A Large-Scale Pharmacoepidemiologic Study Using Real-World Data.

Cardiovasc Drugs Ther

February 2024

Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China.

Purpose: Acute kidney injury (AKI) following anticoagulant application has received growing attention as a significant emerging complication of anticoagulation. Nevertheless, there remains a lack of real-world studies to compare the incidence, clinical features, and prognosis of AKI across different anticoagulant regimens.

Methods: Disproportionality analysis and Bayesian analysis were used to identify suspected AKI cases after different anticoagulant use within the Food and Drug Administration's Adverse Event Reporting System from January 2004 to March 2023.

View Article and Find Full Text PDF

Patients who receive heart valve surgery need anticoagulation prophylaxis to reduce the risk of thrombosis. Warfarin often is a choice but its dosage varies due to gene and clinical factors. We aim to study, among them, if there is an interaction between acute kidney injury and two gene polymorphisms from this study.

View Article and Find Full Text PDF

Anticoagulant-related nephropathy (ARN) is a rare, newly recognized cause of acute kidney injury and significant but underdiagnosed complication of anticoagulation therapy. ARN occurs in patients taking oral anticoagulant therapy most often warfarin or a novel oral anticoagulant (NOAC). It is a potentially devastating disorder with serious renal consequences and increased all-cause mortality.

View Article and Find Full Text PDF

Warfarin is associated with anticoagulant-related nephropathy (ARN), one of the potential side effects. This is evidenced by a progressively increasing number of detected cases of deterioration in the kidney function even in patients with normal baseline function (GFR {glomerular filtration rate}) in addition to the chronic kidney disease (CKD) patients who are already vulnerable to ARN. There has been a clinical correlation in a rapid decline of kidney function and international normalized ratio (INR) levels of greater than three.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!